Background and objective: Glucagon-like-peptide-1 (7-36) amide (GLP-1) is an insulin secretagogue and potential treatment for type II diabetes mellitus. An alternative to GLP-1 administration is endogenous dietary stimulation. We described a greater GLP-1 release following ingestion of liquids versus solids. We add to this work studying the effect of fluid preloads with differing glycaemic indices (GI) on the metabolic response to a meal. Subjects and design: GLP-1, insulin and glucose responses were measured in six overweight individuals and six subjects with type II diabetes on three occasions, after preload (milk, low GI; Ovaltine Light, high GI; or water, non-nutritive control) and meal ingestion. Results: In people with and without diabetes, the high GI preload produced the greatest glucose incremental area under the curve (IAUC) 0-20 , followed by the low GI preload, and water (Po0.001). In both groups, insulin IAUC 0-20 was higher following high and low GI preloads compared with water (NS). In people without diabetes, the GLP-1 response was higher when high and low GI preloads were consumed compared with water (P ¼ 0.041), with no significant difference between nutritive preloads. GLP-1 response did not differ between preloads in people with diabetes. Despite initial differences, total IAUCs 0-200 for biochemical variables did not differ by preload. Conclusion: We confirm that nutritive liquids stimulate GLP-1 to a greater extent than water in subjects without diabetes; however, this does not influence subsequent meal-induced response. The GI of preloads does not influence the degree of GLP-1 stimulation.
Introduction
Glucagon-like peptide-1 (7-36) amide (GLP-1) is a gut hormone released from the L cells in the mucosa of the jejunum, ileum and colon in response to the ingestion of carbohydrate and fat. It is one of the incretin hormones, responsible for the greater rise in insulin following oral as opposed to intravenous glucose (Kreymann et al., 1987) . As well as stimulating its secretion GLP-1 also promotes insulin gene expression and beta-cell growth and differentiation (Hui et al., 2001) . Additionally, GLP-1 inhibits glucagon secretion, gastric emptying (GE) and appetite (Layer et al., 1995; Flint et al., 1998) Therefore, GLP-1 has potential to be used as a therapeutic agent for diabetes. Studies have demonstrated that the intravenous (i.v.) (Nauck et al., 1993; Kjems et al., 2003) or subcutaneous (s.c.) (Gutniak et al., 1994; Todd et al., 1999) administration of GLP-1 successfully lowers blood glucose concentrations and leads to weight loss (Zander et al., 2002) . However, as GLP-1 is a peptide it cannot be administered orally because of enzymatic digestion; it has to be given invasively via i.v. or s.c. injection. An alternative treatment would be to endogenously stimulate GLP-1 using dietary factors.
A study has shown that a liquid meal causes the release of significantly more GLP-1 compared with an identical solid meal in healthy individuals (Brynes et al., 1998) . Jenkins et al. (1981) developed the glycaemic index (GI) in 1981 as a method of quantifying the blood glucose response to a specific food. Low GI diets improve glycaemic control (Frost et al., 1996; Jarvi et al., 1999; Brynes et al., 2003) . It is possible that an increase in release of GLP-1 contributes to the improvement in glucose tolerance.
This study aims to investigate the effect of a high (Ovaltine Light) versus a low GI (milk) preload on initial GLP-1 release and the subsequent metabolic response to a test meal. Milk was chosen as it has previously been shown to have an insulin index (II) that is 3-4 times higher than expected given its low GI (Ostman et al., 2001; Hoyt et al., 2005) . The dissociation of the GI and II of milk has been shown to be unrelated to its fat content (Hoyt et al., 2005) . The addition of milk to a low GI meal increased the insulin incremental area under the curve (IAUC) compared to that of a high GI meal. It is possible that a component of milk stimulates GLP-1, resulting in an insulinotrophic effect.
As research suggests an impaired incretin response in type II diabetes (Vilsboll et al., 2001 (Vilsboll et al., , 2003 Lugari et al., 2002) , the study was carried out in overweight people with (DM) and without diabetes mellitus (NDM) to allow comparisons between the groups.
In this study, we hypothesize that the low GI preload will produce a greater and more sustained release of GLP-1, which will result in an improved metabolic response to a subsequent mixed meal.
Methods

Subject characteristics
Seven DMs (five female, two male) and seven NDMs (four female, three male) were recruited. NDMs had a mean body mass index (BMI) of 30.375.8 kg/m 2 , were in good health, with no clinically significant illness and normal fasting glucose levels. DMs were controlled on oral medication only, mean BMI was 36.877.0 kg/m 2 . No significant difference was observed with respect to BMI (P ¼ 0.083) between DMs and NDMs. One NDM female dropped out of the study because she was very difficult to cannulate; one DM female left the study because of recurrent hypoglycaemia and medical complications. The removal of these subjects from the data set resulted in a significant difference in BMI (P ¼ 0.043) and weight (0.006) between groups. The baseline characteristics of subjects that completed the study are presented in Table 1 . All subjects gave informed written consent after the purposes, nature and potential risks of the study were explained to them. Ethical approval was obtained from the Hammersmith and Queen Charlotte's and Chelsea Research Ethics Committee.
Experimental protocol
The study was a randomized controlled trial, with a within subject, repeated measures and crossover design. Subjects were studied in random order on three separate occasions, separated by a minimum of 72 h. Subjects attended the clinical investigation unit at Hammersmith Hospital at 0800 hours, following a 12 h fast. Upon arrival, an i.v. cannula was inserted into the antecubetal fossa for blood sampling. Blood samples and visual analogue scales (VAS) to assess appetite were completed at each time point (Figure 1 ). VAS consist of straight lines headed by questions such as 'How hungry do you feel right now?' tagged at one end with the words 'not at all' and at the other end with the word 'extremely'. Subjects are asked to mark the scale with a vertical line indicating their degree of hunger. The distance from the left-hand negatively tagged end to the mark is measured in millimetres. In this study, we measured hunger, fullness, desire to eat, prospective food consumption and the palatability of the preloads. Preloads were consumed in 5 min and the meal was completed within the 30-min period between blood samples.
Nutritional content
The preloads tested were 300 ml skimmed milk (GI 32, 99 kcal, 57% of energy from carbohydrate, 3% from fat and 40% from protein), 300 ml Ovaltine Light (GI 105, 97 kcal, 71% energy from carbohydrate, 15% from fat and 10% from protein), which were isocaloric, and 300 ml water, as a non-nutritive control. The volumes were chosen to reflect amounts consumed under normal circumstances. The subsequent test meal was made up of 60 g wholemeal bread, 18 g 70% fat polyunsaturated margarine, 40 g Weetabix, 250 ml semi-skimmed milk, 15 g glucose powder and 250 ml decaffeinated tea or coffee (GI 102, 550 kcal, 56% energy from carbohydrate, 31% from fat and 13% from protein).
Gastric emptying GE was estimated using the Paracetamol absorption technique (Tarling et al., 1997) , as Paracetamol is not absorbed in the stomach, but it rapidly enters the blood stream from the small intestine (Rawlins et al., 1997) . Soluble Paracetamol (1.5 g) was dissolved in 100 ml water and given half way through the meal. Paracetamol analysis was carried out by the Clinical Chemistry Department using an enzymatic assay (Olympus Diagnostics, Southall, UK) on an Olympus AU600 analyser. The detection limit using this method is estimated to be 0.01 mmol/l.
Biochemical analysis
Blood samples (10 ml) were collected into lithium heparin tubes containing 4000 kIU aprotinin (Trasylol, Bayer PLC, Newbury, Berkshire, UK). Blood for glucose sampling (4 ml) was collected into tubes containing fluoride oxalate and samples for Paracetamol analysis were collected into plain tubes. Blood was centrifuged at 3000 r.p.m at 51C, plasma was separated and frozen at À201C until analysis. GLP-1 and insulin concentrations were measured using specific inhouse radioimmunoassays as described previously (Todd et al., 1999) . All samples were assayed in duplicate within one assay to reduce inter-assay variation. The inter-and intra-assay coefficients of variation were less than 10% for the insulin assay, which was able to detect changes of 6 pmol/l with 95% confidence (Kreymann et al., 1987) . The GLP-1 assay was capable of detecting 2 pmol/l with a 95% confidence. Plasma glucose was analysed using a glucoseoxidase-based autoanalyser (Technicon, Axon Bayer Diagnostic, Newbury, Berkshire, UK).
Statistical analysis
The power calculation was based on our previous study (Brynes et al., 1998) , where a difference in GLP-1 IAUC of 1.1 nmol/min and a s.d. of 0.6 nmol/min produced a significant impact on insulin release. Assuming a power of 85% and a ¼ 0.05, a sample of six people per group would be needed. Results are displayed as the mean7s.e. of the mean. IAUC was calculated for glucose, insulin, GLP-1 and Paracetamol concentrations, using the trapezoidal rule.
Comparison between raw data for the three preloads was undertaken using repeated-measures analyses of variance (ANOVAs) with time and preload treatment as within subject factors. The IAUCs were compared between preloads using a repeated measures ANOVA with preload treatment as the within subjects factor; post hoc analysis was carried out with paired-sample t-tests. Differences in postprandial responses between DMs and NDMs were assessed using repeatedmeasures ANOVAs with diabetes status as a between subject factor. All analysis was performed using SPSS software (version 11.5) and Po0.05 was taken as statistically significant.
Results
To see the effect of the preload alone the IAUC for all variables was split into two time periods, 0-20 min and 0-200 min.
Preload effect (0-20 min) Glucose (NDMs and DMs). The IAUC 0-20 was significantly different between the three preloads in NDMs (P ¼ 0.001; Figure 2 ) and DMs (P ¼ 0.002; Figure 3) , with no significant effect of diabetes status on the IAUC 0-20 . Ovaltine consumption produced a significantly greater glucose response than either water or milk in both groups (Po0.001). Post hoc analysis revealed that in NDMs the glucose response to milk did not differ significantly from that of water (P ¼ 0.46). In DMs, milk produced a greater glucose IAUC 0-20 than water (P ¼ 0.03).
In NDMs, analysis of data showed a significant effect of the preload (P ¼ 0.023) and of time (P ¼ 0.001) on blood glucose concentrations. In DMs, the difference between preloads did not reach statistical significance; however, there was a significant time effect (P ¼ 0.001) and a preload Â time interaction (Po0.001). Owing to differences in fasting glucose between visits, in DMs results were also analysed as GLP-1 response to low versus high GI JE Milton et al changes from baseline. Following this analysis, the difference between preloads reached significance (P ¼ 0.003).
Insulin (NDMs and DMs)
The IAUC 0-20 did not differ significantly between preloads in NDMs (P ¼ 0.056; Figure 4 ) or DMs (P ¼ 0.901; Figure 5 ); nor were there any significant differences in the insulin response between the groups. In NDMs, the analysis of data revealed no significant effect of the preload, but a significant effect of time (P ¼ 0.006) and a trend towards a time Â treatment interaction (P ¼ 0.076). In DMs, there was neither an effect of the preload or of time on insulin concentrations. To examine the relationship between insulin and glucose release on each preload visit, the ratio of insulin to glucose was calculated for the Ovaltine and milk visits, compared with water, which was set as 1.0 for both NDMs and DMs. The insulin:glucose ratio for the Ovaltine visit was 0.54 in NDMs and 0.35 in DMs; on the milk visit the ratio was 6.82 for NDMs and 1.78 for DMs.
GLP-1 (NDMs and DMs)
The IAUC 0-20 was not significantly different between preloads in NDMs (Figure 6 ) or DMs (Figure 7) , nor was there a significant difference between subject groups. Analysis of data revealed no significant difference in NDMs between the preloads, nor was there an effect of time on GLP-1 concentrations. In DMs, the GLP-1 response did not differ between preloads, but there was an effect of time (P ¼ 0.033).
Preload and meal effect (0 to 200 min) Glucose (NDMs and DMs). The IAUC 0-200 was not significantly different between the preloads in either DMs (Figure 3) or NDMs (Figure 2) . On all three visits, the IAUC 0-200 was significantly greater in DM subjects than in NDMs (P ¼ 0.001). When the data were analysed over the whole time period, there was a significant effect of time on the plasma glucose levels in NDMs (Po0.001) and DMs (Po0.001). Blood glucose increased significantly after preload and meal consumption and then gradually fell back towards baseline. In both groups, there was a significant interaction between time and preload treatment (NDM P ¼ 0.001; DM P ¼ 0.005). Owing to differences in fasting glucose concentrations in the DM group, results were also examined as changes from baseline. This analysis revealed a trend towards significant effect of the preload on blood glucose levels (P ¼ 0.078).
Insulin (NDMs and DMs)
The IAUC 0-200 for insulin response did not differ significantly between preloads in either NDMs (Figure 4 ) or DMs ( Figure 5 ). No significant differences were revealed between DMs and NDMs in terms of the total postprandial insulin response. Data analysis showed no effect of the preload on insulin; in both groups time exerted a significant effect on the insulin concentrations (Po0.001) and in NDMs there was a significant preload Â time interaction (P ¼ 0.022).
GLP-1 (NDMs and DMs).
The IAUC 0-200 for GLP-1 response did not differ significantly between preloads in either group. The IAUC 0-200 was lower in DMs ( Figure 7 ) compared with NDM ( Figure 6 ) subjects on all three visits, but the differences failed to reach statistical significance. As the mean BMI was higher in the DM group, this may have masked their lower GLP-1 response. Therefore, the GLP-1 IAUC 0-200 was analysed per BMI unit (data not shown). Again the GLP-1 response was lower in DMs, but differences did not reach statistical significance. Analysis of the data demonstrated a significant effect of time on GLP-1 concentrations in NDMs (P ¼ 0.001) and DMs (Po0.001). Levels increased significantly after preload and meal consumption, reaching a peak between 50 and 80 min 
GLP-1 response to low versus high GI
JE Milton et al after the preload and then falling back towards fasting levels. The type of preload had no significant effect on GLP-1 concentrations over the 200 min study period, nor was there a time Â treatment interaction in either group. No significant differences were observed between NDMs and DMs with regard to the GLP-1 response.
Estimate of gastric emptying (NDMs and DMs)
The Paracetamol was given with the meal; therefore, the IAUC was calculated from time 20 to 200 min. The IAUC did not differ between preloads or between NDMs (Figure 8 ) and DMs ( Figure 9 ). The analysis of data revealed a significant effect of time (Po0.001) on Paracetamol concentrations in both groups. Paracetamol levels increased significantly after the meal, peaking between 65 and 95 min after the preload and then falling towards baseline levels. In NDMs, there was a significant effect of preload type on Paracetamol concentrations (P ¼ 0.033). There was no difference between preloads in DMs with respect to the raw data.
Hunger and fullness (data not shown) There was a significant time effect in hunger ratings in NDMs (Po0.001) and DMs (P ¼ 0.023). Ratings were high at the start of the study period, fell after eating and then gradually increased towards fasting levels. No effect of the preload was observed when results were analysed as raw data. Additionally, there was no difference in hunger ratings between NDMs and DMs. Fullness changed significantly over time in both groups (Po0.001). Ratings were low initially, peaked 50 min after the preloads and slowly fell back towards fasting ratings. Analysis of data for fullness showed no differences between preloads or between NDMs and DMs.
Palatability
In NDMs, Ovaltine had the highest taste rating of 64.2735.0 mm, followed by milk rated at 17.7725.9 mm and lastly water at 2.372.7 mm (Po0.05). Post hoc analysis revealed no significant difference between milk and water. In DMs, milk had the highest taste rating of 62.5725.1 mm, followed by Ovaltine rated at 49.7718.1 mm and lastly water at 11.879.4 mm (Po0.01). No significant difference was found between milk and Ovaltine when post hoc analysis was carried out.
Discussion
The current study investigated whether a preload could stimulate GLP-1 and subsequently reduce the postprandial glucose excursion following a meal given 20 min later.
Comparisons were made between a non-nutritive preload and two isocaloric and isovolumetric preloads, one with a high (Ovaltine) and one with a low (milk) GI. We hypothesized that the consumption of a low GI preload would result in a greater GLP-1 release. In both groups, the GLP-1 release was greater with the low GI preload, although differences failed to reach significance. The difference in initial glucose release between preloads was not associated with significant differences in insulin or GLP-1 during this period. This and the ratios of insulin:glucose suggest that milk stimulates a disproportionately high insulin and GLP-1 secretion considering its low glycaemic effect. Differences observed during the initial 20 min did not impact significantly on the IAUC 0-200 over the whole study period. The high GI preload (Ovaltine) consumption resulted in a significant increase in blood glucose in both NDMs and DMs. This was expected given its high GI of 110; the insulin response was also the highest of the three preloads, although not significantly different from water or milk. The insulin release following ingestion normally correlates with the glycaemic response (Truswell, 1992) . However, the fact that the preload was chocolate flavoured and found to be more palatable may have contributed to the greater insulin response. Chocolate and cocoa-based foods exhibit a similar disproportionately high insulin response given their relatively low GI (Shively et al., 1986; Holt et al., 1997 ; -Miller et al., 2003) . Foods rated as highly palatable enhance the cephalic phase of insulin release (Teff and Engelman, 1996) .
Brand
Milk failed to significantly increase glucose in NDMs, but did produce a near fourfold greater insulin response than water over the first 20 min. In DMs, milk significantly increased glucose levels compared with water, but stimulated insulin to a lesser extent than in NDMs (1.9-fold greater than water). The finding in NDMs supports previous work that has shown milk to have a higher than expected insulin index (Ostman et al., 2001) . In NDMs, GLP-1 release was significantly increased after the consumption of milk compared with water; however, in the DM group there was no significant difference in the initial GLP-1 response between the three preloads. These observations suggest that milk may have a higher insulin index, because of a greater stimulation of GLP-1 in NDMs.
The Paracetamol IAUC did not differ between the Ovaltine and milk preloads in either group. Previously we did not measure GE, although glucose concentrations did not differ between meals suggesting no difference (Brynes et al., 1998) . A solid, liquid or pharmaceutical agent that does alter the rate of GE could result in a difference in the subsequent metabolic response. Recent evidence indicates that the rate of small intestinal glucose delivery is important in GLP-1 release (O'Donovan et al., 2004) . The principle source of carbohydrate in milk is lactose (4.6g/100 ml), a disaccharide of glucose and galactose. Milk initially produced a much lower glucose response than Ovaltine, which contains lactose in a smaller quantity (2.7 g/100 ml), as well as sucrose (1.4 g/100 ml) and maltose (0.75 g/100 ml). It is possible that the delay resulting from lactose digestion causes a sustained release of GLP-1. demonstrated that galactose has the GLP-1 releasing property.
However, milk has been shown to produce a greater insulin response than lactose and water (Ostman et al., 2001) , signifying that something other than lactose stimulates insulin secretion. Eighty percent of milk proteins are casein and 20% are whey; whey has been shown to be a more powerful insulin secretagogue than milk and to stimulate GLP-1 and the incretin hormone glucose-dependent insulinotrophic polypeptide (Nilsson et al., 2004) . The protein fraction of milk, an additive effect of lactose and amino acids, the incretins, or other hormones or peptides have been implicated in milks insulinogenic effect (Nilsson et al., 2004; Hoyt et al., 2005) .
Despite the significant difference in the glucose response and nonsignificant differences in insulin and GLP-1 response between the preloads over the initial 20-min period, there are no significant differences between the preloads when looking at the total 200-min response. In NDMs, the consumption of a meal containing 78 g of carbohydrate barely increased blood sugars any further when preceded by a preload of Ovaltine Light, containing 18 g of carbohydrate. This is likely to be because blood glucose is tightly controlled (between 4 and 10 mmol/l) in NDMs therefore, following the preload-induced increase to 6.9670.90 mmol/l the surge of insulin prevented a further substantial increase in blood glucose. Conversely on the water and milk visits, the preload alone did not significantly affect blood glucose; hence, the meal response was more pronounced. In DMs, the consumption of the meal further increased blood glucose on all three visits. However, the peak blood glucose did not differ between visits in either group, despite 15 g of additional carbohydrate on the milk visit and 18 g on the Ovaltine visit.
The initial differences in the blood glucose response between study days had no significant effect on hunger and fullness ratings. In part, this may be due to the diversity of the groups in terms of weight, body composition and potentially insulin resistance. If blood glucose does have a physiological role in appetite control then the magnitude of the differences in glucose over the time period may not have been sufficient to alter hunger sensations.
Although lower in DMs the IAUC 0-200 for GLP-1 did not differ significantly between NDMs and DMs. As the groups were not weight matched the postprandial GLP-1 response was examined per BMI unit. Again this was lower in DMs, but did not reach statistical significance. This finding conflicts with previous studies that have observed a significantly reduced postprandial GLP-1 response in DMs (Toft-Nielsen et al., 2001; Vilsboll et al., 2001 Vilsboll et al., , 2003 Lugari et al., 2002) . However, the low GI preload significantly stimulated GLP-1 in NDMs, but not in DMs, suggesting that DMs need a larger carbohydrate/cal load to stimulate GLP-1. An alternative explanation for the lack of difference between subject groups is the observation in some studies of a reduced GLP-1 response in obese subjects without diabetes (Ranganath et al., 1996; Verdich et al., 2001; . As all subjects in this study were overweight, an impaired GLP-1 response may have been present in all subjects, masking any differences between NDM and DM groups.
Limitations of this study include the small sample size and the fact that the DM and NDM groups were not matched for weight or BMI. In order to compare the effect of splitting a larger meal into a smaller meal and preload, it would have been of interest to carry out a fourth visit. On this visit, subjects would have still been given a water preload followed by a meal containing 650 cal and 15-18 g of additional carbohydrate. This would have allowed for a more direct comparison between the nutritive preload visits and the water visit, as the total calorie and carbohydrate loads would have been identical.
Conclusion
We reinforce the previous finding that nutritive liquids stimulate GLP-1 release to a greater extent than water. Liquids with differing GIs do not differ in their rate of gastric emptying, nor their ability to stimulate GLP-1. Differences in glucose response were apparent between the preloads in both groups when they were consumed alone, but the initial metabolic effects of the preload blunt those of the meal, thereby resulting in the same total IAUC 0-200. Milk does appear to stimulate a greater than expected amount of insulin and GLP-1, given its low GI, especially in NDMs. Further studies are required to support this finding and elucidate the component responsible for this observation.
